197 Collectively, these pleiotropic effects position GLP-1R agonists as promising therapeutic agents for improving cardiovascular outcomes, extending their benefits far beyond glycemic control
(2009) Supplementation of L-carnitine in pigs: Absorption of carnitine and effect on plasma and tissue carnitine concentrations
, Most studies have shown the benefit of L-carnitine on cardiovascular risk factors
GLP-1 and Amylin in the Treatment of Obesity
As prescribing rates climb, awareness of GLP-1 dermatologic effects becomes essential for safe and informed practice
Its versatility covers numerous research areas, including obesity, metabolic syndrome, diabetes, and cardiovascular health